Compare CTRN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTRN | VALN |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.1M | 495.5M |
| IPO Year | 2005 | 2021 |
| Metric | CTRN | VALN |
|---|---|---|
| Price | $72.71 | $7.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $52.00 | $15.50 |
| AVG Volume (30 Days) | ★ 114.3K | 67.8K |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.14 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $819,962,000.00 | N/A |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $8.35 | $93.87 |
| P/E Ratio | $80.86 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $29.60 | $4.75 |
| 52 Week High | $77.91 | $12.25 |
| Indicator | CTRN | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 61.59 | 85.28 |
| Support Level | $42.10 | $5.03 |
| Resistance Level | $77.91 | $9.56 |
| Average True Range (ATR) | 2.83 | 0.20 |
| MACD | -0.16 | 0.23 |
| Stochastic Oscillator | 59.41 | 93.31 |
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.